PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.

Marie Beck EnemarkIda MonradCharlotte MadsenKristina Lystlund LauridsenBent HonoréTrine Lindhardt PlesnerStephen Jacques Hamilton-DutoitFrancesco d'AmoreMaja Ludvigsen

Published in: OncoTargets and therapy (2021)

Our data suggest that pre-treatment tumor-tissue PD-1 expression already predicts the risk of subsequent transformation to DLBCL, as early as the time of FL diagnosis.

Keyphrases

high grade
poor prognosis
combination therapy
machine learning
long non coding rna
smoking cessation